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Background: Persistent MRSA infection in CF patients can affect clinical status.
The geographical diffusion of MRSA clones remains poorly investigated. The aim
of this study is to highlight MRSA epidemiology in a national survey.
Strains and Methods: 443 MRSA strains belonging to 235 patients attending 11 CF
Italian centres were collected over a 4-year period. SCCmec typing was performed
according to published protocols, as well as Multi Locus Sequence Typing (MLST)
analysis.
Results: SCCmec typing was performed on 371 MRSA strains: 156 (42%) strains
were characterised by SCCmec IV (mainly associated with CA-MRSA), while 175
(47%) had SCCmec I, II or III (associated with HA-MRSA). The prevalence of
SCCmec IV was 42% in Nothern Italy while in the Centre and in Southern Italy
it was 28% and 31% respectively. MLST analysis was performed on 111 out of
443 strains, showing that the majority of clones were ST228-MRSA-I (26%) and
ST8-MRSA-IV (9.9%).
Conclusions: This preliminary data shows that SCCmec IV, mainly associated with
CA-MRSA, have a higher diffusion in Northern Italy. Different hospitalisation rates
and/or segregation practices, can be hypothesised to explain these ﬁndings. More
data is needed to clarify these differences in MRSA epidemiology.
This work was supported by Italian Cystic Fibrosis Research Foundation (grant
FFC#11 2009) with the contribution of Angelini.
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Objective: The purpose of this study was to investigate the genotype distribution of
S. maltophilia isolates from patients with cystic ﬁbrosis (CF) by repetitive sequence-
based PCR using the DiversiLab® System.
Methods: Sputum samples (n = 787) from 169 CF patients were inoculated onto a
selective medium for improved isolation of S. maltophilia. Suspected isolates were
identiﬁed by established phenotypic methods, as well as by DNA sequencing. A total
of 63 S. maltophilia isolates from 14 CF patients were detected. For genotyping,
DNA extraction was performed with the UltraCleanTM microbial DNA isolation
kit (Mo Bio Laboratories, Carlsbad, CA, USA), according to the manufacturer’s
instructions. DiversiLab® bacterial DNA ﬁngerprinting kit (bioMe´rieux, Marcy
L’Etoile, France) was used for typing. The relatedness degree of the isolates was
determined by cluster analysis using Pearson’s Correlation coefﬁcient. Isolates with
a similarity of 95% were considered as “clinically related” (clone), and isolates
with a similarity >98% were considered as “indistinguishable” genotypes.
Results: DiversiLab proﬁles from all patients’ isolates exhibited one dominant
colonising/infecting clone. It was also observed that two patients (15%) had more
than one genotype. Only a small proportion of isolates from different patients (n = 5)
were indistinguishable genotypes (9.52%), suggesting either cross-transmission or
a common source of exposure of unclear origin.
Conclusions: CF patients possess a dominant S. maltophilia clone and genotypic
variants may coexist. Further epidemiological studies are required to elucidate the
route of colonisation/infection in CF patients.
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Introduction: Viral respiratory infections are common in CF and are frequently
associated with pulmonary exacerbations. PCR-based assays are highly sensitive for
respiratory viruses but are limited by high processing costs and variable availability.
Objectives: We investigated whether symptoms of an upper respiratory tract
infection (URTI) predict laboratory-conﬁrmed viral respiratory infection in adults
with CF.
Methods: 100 adults with CF were recruited to a prospective study examining
the incidence & impact of viral infections. Sputum, nose- and throat-swabs were
collected and tested with PCR-based assays for adenovirus, inﬂuenza, metapneu-
movirus, parainﬂuenza virus, respiratory syncytial virus & rhinovirus. A 27-point
URTI symptom score (Johnston et al BMJ 1993) was recorded. A score of 4 has
previously been used to diagnose URTI. Receiver operating characteristic (ROC)
analysis was performed.
Results: 19/100 recruitment visits were positive for 1 virus (9 rhinovirus, 7
inﬂuenza & 3 metapneumovirus). Mean (SD) URTI score was 9.6 (7.4) in the
virus-positive group & 5.0 (4.7) in the virus negative group (p = 0.01). ROC analysis
revealed an area under the curve of 0.69 for the URTI score. An URTI score cut-
off of 4 gave a sensitivity & speciﬁcity of 74% & 51% respectively. Optimal
performance of the URTI score was achieved with a cut-off of 12 which gave a
sensitivity & speciﬁcity of 42% & 88% respectively. Positive & negative predictive
values for a score of 12 were 44% & 87%.
Conclusions: Symptoms of an URTI as measured by this symptom score are poorly
predictive of laboratory-conﬁrmed viral respiratory infection in adults with CF.
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Aims: To:
• deﬁne the prevalence of CF patients colonized by extended-spectrum beta-
lactamase-producing Enterobacteriaceae
• establish length of colonization
• emphasise the role of such pathogens in spreading resistance determinants
Material and Methods: Sputa of pts with CF and Schwachmann Syndrome found
positive for Enterobacteriaceae producing extended-spectrum beta-lactamases were
evaluated. Cultures were processed according to the National and International
Guidelines for the research of bacteria and fungi.
ESBL production was conﬁrmed in accordance with CLSI recommendations. Pulsed
ﬁeld gel electrophoresis was used to deﬁne the clonal relationship.
Results: Between 1 September 2010 and 30 August 2011, we evaluated the cultures
of the respiratory secretions of 350 pts; 15 pts (13 CF and 2 with Schwachmann
Syndrome, 9 males, average age 3.5 years, range 1−32 years) resulted colonized by
Enterobacteria producing extended-spectrum beta-lactamases (13 Escherichia coli;
1 Klebsiella oxytoca; 1 K. pneumoniae).
Prevalence rate was 4.2%; in 5 pts colonization was higher than 6 months and in 2
higher than 1 year. Three pts showed only 1 isolate; for the others the observation
period was too short.
Conclusions: In the last year, we observed an increase of number of pts colonized by
Enterobacteria producing ESBL that have a key epidemiological role for spreading
the resistance genetic determinants. As a long time persistence of such pathogens
in CF lung makes it a reservoir of resistance determinants, strict infection control
measures must be taken in order to avoid dissemination.
